_________________
May 15, 2018 | Dr. Ajaz Hussain has once again been recognized for his contributions as one of the top 100 inspirational industry professionals by the Medicine Maker magazine under the Industry Influencer category. This is the third time Dr. Hussain has been selected for this recognition.
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced the opening of its new subsidiary in Netherlands to support the company’s expansion into key European markets and provide on-the-ground sales and customer support for current clients, prospects and partners in the region.
The flexibility of ValGenesis’ automated workflows, forms designer and process designer platform will make Validation, Risk Assessment and Change Management processes easier while significantly reducing the time it takes to accomplish these tasks. Furthermore, the system enables compliance and standardization across the entire organization whilst enforcing good document practices and ensuring data integrity.
Infosys’ Life Sciences Practice works with 50+ leading pharmaceutical and medical devices companies, providing premium regulatory, quality and compliance services. Infosys will deploy the ValGenesis Validation Lifecycle Management System (VLMS) to its customers as a single “paperless” system that manages every activity in the entire validation lifecycle.
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide clients with validation services using the latest technology available in the ValGenesis VLMS system.
Dr. Ajaz Hussain brings a wealth of international pharmaceutical regulatory and business experience to ValGenesis, including his decade-long tenure with the United States Food and Drug Administration (US FDA), Center for Drug Evaluation and Research (CDER).
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS), is pleased to announce the issuance of a patent on paperless validation, #9,720,687. The patent granted by the U.S. Patent and Trademark Office (USPTO) focuses on ‘Validating and Maintaining Respective Validation Status of Software Applications, Manufacturing Systems and Business Processes’.
ValGenesis, Inc., announced that a globally renowned Medical Device manufacturer will be presenting a case study about their experience with the paperless validation process. In the study, the medical device manufacturer explains how the paperless validation process helped to improve upon their efficiency while also standardizing the validation process across their sites.
Accessing ValGenesis VLMS through the enterprise-ready validated ValGenesis Cloud, allows companies to implement and deploy the system rapidly with less investment and in a shorter period of time.
ValGenesis VLMS provides a holistic view of the Validation process throughout the company with validation activities accessible in real-time from a convenient dashboard within ValGenesis. VLMS provides a direct line to validation tasks, inventory, work in progress, calendars, projects, reports, and a 360-degree view of GxP systems and assets by site.